- Home
- ALGS vs PLSM Comparison
ALGS vs PLSM Comparison
Compare ALGS & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | PLSM |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 38.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALGS | PLSM |
|---|---|---|
| Price | $6.37 | $3.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 188.6K | 2.9K |
| Earning Date | 05-05-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $32.20 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $3.00 |
| 52 Week High | $13.69 | $6.85 |
Technical Indicators
Market Signals| Indicator | ALGS | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 40.40 |
| Support Level | N/A | $3.00 |
| Resistance Level | $8.03 | $3.93 |
| Average True Range (ATR) | 0.72 | 0.21 |
| MACD | -0.20 | 0.04 |
| Stochastic Oscillator | 13.33 | 39.78 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About PLSM Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.